Search Results - "Aguero, Martin F"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Phenoxodiol inhibits growth of metastatic prostate cancer cells by Aguero, Martin F., Venero, Marina, Brown, David M., Smulson, Mark E., Espinoza, Luis A.

    Published in The Prostate (01-08-2010)
    “…BACKGROUND Phenoxodiol, a synthetic analog of Genistein, is being assessed in several clinical studies against a range of cancer types and was shown to have a…”
    Get full text
    Journal Article
  2. 2

    Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1 by Aguero, Martin F, Facchinetti, Maria M, Sheleg, Zhanna, Senderowicz, Adrian M

    Published in Cancer research (Chicago, Ill.) (15-04-2005)
    “…Phenoxodiol, an isoflavone derivative of genistein with unknown mechanism of action, is currently being evaluated in early human cancer clinical trials. To…”
    Get full text
    Journal Article
  3. 3

    Abstract 3990: Methods for Fine Needle Aspiration (FNA) biopsy sampling and “ex vivo” signal transduction analysis of murine xenografted human tumors by Aguero, Martin F., Jeffries, Emiko, Schayowitz, Adam, Clark, Douglas P.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract Fine Needle Aspiration (FNA) biopsy is a common procedure for sampling human tumors to enable diagnosis and, increasingly, molecular diagnostics on…”
    Get full text
    Journal Article
  4. 4

    Phenoxodiol, a Novel Isoflavone, Induces G sub(1) Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21 super(WAF1/CIP1) by Aguero, Martin F, Facchinetti, Maria M, Sheleg, Zhanna, Senderowicz, Adrian M

    Published in Cancer research (Chicago, Ill.) (01-04-2005)
    “…Phenoxodiol, an isoflavone derivative of genistein with unknown mechanism of action, is currently being evaluated in early human cancer clinical trials. To…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Bryostatin-1 and IL-2 synergize to induce IFN-gamma expression in human peripheral blood T cells: implications for cancer immunotherapy by Curiel, R E, Garcia, C S, Farooq, L, Aguero, M F, Espinoza-Delgado, I

    Published in The Journal of immunology (1950) (01-11-2001)
    “…Bryostatin-1 (Bryo-1), a protein kinase C modulator with antineoplastic activity, may exert some of its antitumor activity through activation of the immune…”
    Get full text
    Journal Article
  7. 7